EyePoint Pharmaceuticals Inc.
EYPT | NASDAQ
$4.03
+$0.01 (+0.25%)
Sep 22, 2026, 2:30 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -179.3M | -84.83M | -67.61M | -59.73M | -59.43M | -45.2M | -41.4M | -29.36M | -30.83M | -29.28M | -14.1M | -12.61M | -22.92M | -21.16M | -43.45M | -18.42M | -19.41M | -20.98M | -19.43M | -16.7M | -10.01M | -12.28M |
Depreciation & Amortization | 1.33M | 636K | 698K | 576K | 538K | 497K | 467K | 408K | 362K | 303K | 112K | 115K | 132K | 105K | 335K | 711K | 704K | 696K | 698K | 701K | 685K | 687K |
Stock-Based Compensation | 22.04M | 11.64M | 6.75M | 6.43M | 6.88M | 7.82M | 7.9M | 7.45M | 8.7M | 12.7M | 3.59M | 3.63M | 1.79M | 3.05M | 3.36M | 3.2M | 4.14M | 3.48M | 2.81M | 2.47M | 1.18M | 988K |
Other Working Capital | -3.47M | -3.39M | -58K | -51K | -5.09M | -23.09M | -11.6M | 17.14M | -5.46M | -8.27M | -13.4M | -13.84M | 71.79M | -62K | -1.77M | -274K | -173K | -260K | -5.26M | -233K | -217K | -278K |
Other Non-Cash Items | -2.27M | -778K | -1.03M | -861K | -1.29M | -1.73M | -1.72M | -28.55M | -1.69M | -575K | -522K | -3.72M | -51K | -244K | 22.31M | -214K | -114K | 1.67M | 166K | 162K | 153K | 147K |
Deferred Income Tax | n/a | n/a | 459K | -90K | n/a | n/a | n/a | n/a | n/a | n/a | 83K | 3.69M | 2.04M | n/a | n/a | n/a | n/a | n/a | 1.28M | n/a | -2.07M | n/a |
Change in Working Capital | 15.31M | -7.21M | -4.31M | -5.68M | -9.29M | -14.51M | -1.1M | 11.03M | 3.28M | -14.31M | -12.27M | -6.3M | 76.03M | 1.42M | 4.86M | 1.59M | -4.45M | -5.02M | -2.19M | 5.57M | -486K | -4.64M |
Operating Cash Flow | -142.9M | -80.55M | -65.05M | -59.35M | -62.59M | -53.12M | -35.85M | -39.03M | -20.18M | -31.17M | -23.11M | -15.2M | 57.02M | -16.84M | -12.59M | -13.14M | -19.12M | -20.16M | -16.67M | -7.79M | -10.54M | -15.1M |
Capital Expenditures | -2.2M | -997K | -986K | -798K | -1.22M | -276K | -384K | -1.57M | -900K | -1.19M | -883K | -1.72M | -396K | -484K | -585K | -1.2M | -218K | -149K | n/a | -131K | -25K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 46.27M | n/a | -13.86M | -244K | -558K | -7.47M | n/a | 110K | n/a | n/a | n/a | n/a |
Purchase of Investments | -9.95M | -9.95M | -148.84M | -9.82M | -53.94M | -39.42M | -164.08M | -49.23M | -185M | n/a | -49.27M | n/a | -2.92M | -2.93M | -13.5M | -33.53M | -29.79M | -62.29M | -32.97M | n/a | n/a | n/a |
Sales Maturities Of Investments | 145M | 70M | 78.72M | 62.12M | 103.5M | 79.23M | 68.5M | 62.86M | 25.5M | 22M | 3M | n/a | 16.78M | 35.5M | 47M | 41M | 30M | 6M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 1.3M | n/a | -3.57M | 3.89M | n/a | n/a | n/a | 4.14M | -159.5M | 22M | -46.27M | n/a | 13.86M | 244K | 558K | 7.47M | 206K | -110K | -32.97M | n/a | n/a | n/a |
Investing Cash Flow | 134.16M | 59.05M | -74.67M | 55.39M | 48.34M | 39.53M | -95.96M | 16.2M | -160.4M | 20.81M | -47.15M | -1.72M | 13.47M | 32.09M | 32.92M | 6.27M | -12K | -56.44M | -32.97M | -131K | -25K | n/a |
Debt Repayment | 57K | -29K | -27K | -27K | -16K | -35K | -32K | -73K | n/a | n/a | 1.31M | -1.35M | -35.3M | -5.18M | -34K | -36K | -34K | -87K | -44K | -44K | -40K | -18K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -78K | -78K | -4.36M | n/a | n/a | n/a | -169K | -24K | n/a | -21K | -250K | n/a | -7.22M | n/a | -128K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.3M | -3.71M | 273K | -133K | -19K | -1.51M | -365K | 12.04M | -296K | -4.45M | 971K | 10.36M | -1.36M | 61K | -24K | 128K | -242K | -602K | 84K | 7.36M | -12K | -128K |
Financial Cash Flow | 17.38M | -2.61M | 166.96M | 7.4M | 238K | -951K | 151.69M | 11.89M | 329K | 115K | 218.49M | 10.36M | -36.66M | -5.12M | -58K | 92K | -276K | -448K | 108.52M | -2K | -381K | 108.77M |
Net Cash Flow | 8.64M | -24.11M | 27.24M | 3.43M | -14.02M | -14.55M | 19.87M | -10.94M | -180.24M | -10.25M | 148.23M | -6.56M | 33.83M | 10.13M | 20.27M | -6.77M | -19.41M | -77.05M | 58.88M | -7.92M | -10.95M | 93.67M |
Free Cash Flow | -145.09M | -81.55M | -66.03M | -60.15M | -63.81M | -53.4M | -36.23M | -40.6M | -21.08M | -32.37M | -23.99M | -16.92M | 56.63M | -17.32M | -13.17M | -14.33M | -19.34M | -20.31M | -16.67M | -7.92M | -10.57M | -15.1M |
Adj. Free Cash Flow | -167.13M | -93.18M | -72.78M | -66.58M | -70.69M | -61.22M | -44.13M | -48.05M | -29.77M | -45.06M | -27.58M | -20.55M | 54.84M | -20.37M | -16.53M | -17.53M | -23.48M | -23.78M | -19.48M | -10.39M | -11.75M | -16.09M |
Maintenance CapEx | -1.33M | -636K | -986K | -798K | -1.22M | n/a | -384K | -1.57M | -806.81K | -191.71K | -374.37K | -964.7K | -396K | -484K | -585K | -1.08M | n/a | n/a | n/a | -131K | n/a | n/a |
Growth CapEx | -871K | -361K | n/a | n/a | n/a | -276K | n/a | n/a | -93.19K | -1M | -508.63K | -755.3K | n/a | n/a | n/a | -115.84K | -218K | -149K | n/a | n/a | -25K | n/a |
Owner Earnings | -144.22M | -81.19M | -66.03M | -60.15M | -63.81M | -53.12M | -36.23M | -40.6M | -20.98M | -31.36M | -23.48M | -16.17M | 56.63M | -17.32M | -13.17M | -14.22M | -19.12M | -20.16M | -16.67M | -7.92M | -10.54M | -15.1M |
Add to Watchlist
Select watchlists to add or remove EYPT